Hepcidin Protects Yellow Catfish (Pelteobagrus Fulvidraco)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Iron Regulation by Hepcidin
Iron regulation by hepcidin Ningning Zhao, … , An-Sheng Zhang, Caroline A. Enns J Clin Invest. 2013;123(6):2337-2343. https://doi.org/10.1172/JCI67225. Science in Medicine Hepcidin is a key hormone that is involved in the control of iron homeostasis in the body. Physiologically, hepcidin is controlled by iron stores, inflammation, hypoxia, and erythropoiesis. The regulation of hepcidin expression by iron is a complex process that requires the coordination of multiple proteins, including hemojuvelin, bone morphogenetic protein 6 (BMP6), hereditary hemochromatosis protein, transferrin receptor 2, matriptase-2, neogenin, BMP receptors, and transferrin. Misregulation of hepcidin is found in many disease states, such as the anemia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatosis, and ineffective erythropoiesis, such as β- thalassemia. Thus, the regulation of hepcidin is the subject of interest for the amelioration of the detrimental effects of either iron deficiency or overload. Find the latest version: https://jci.me/67225/pdf Science in medicine Iron regulation by hepcidin Ningning Zhao, An-Sheng Zhang, and Caroline A. Enns Department of Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon, USA. Hepcidin is a key hormone that is involved in the control of iron homeostasis in the body. Physi- ologically, hepcidin is controlled by iron stores, inflammation, hypoxia, and erythropoiesis. The regulation of hepcidin expression by iron is a complex process that requires the coordination of multiple proteins, including hemojuvelin, bone morphogenetic protein 6 (BMP6), hereditary hemochromatosis protein, transferrin receptor 2, matriptase-2, neogenin, BMP receptors, and transferrin. Misregulation of hepcidin is found in many disease states, such as the anemia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatosis, and ineffective erythropoiesis, such as β-thalassemia. -
WHITE BLOOD CELLS Formation Function ~ TEST YOURSELF
Chapter 9 Blood, Lymph, and Immunity 231 WHITE BLOOD CELLS All white blood cells develop in the bone marrow except Any nucleated cell normally found in blood is a white blood for some lymphocytes (they start out in bone marrow but cell. White blood cells are also known as WBCs or leukocytes. develop elsewhere). At the beginning of leukopoiesis all the When white blood cells accumulate in one place, they grossly immature white blood cells look alike even though they're appear white or cream-colored. For example, pus is an accu- already committed to a specific cell line. It's not until the mulation of white blood cells. Mature white blood cells are cells start developing some of their unique characteristics larger than mature red blood cells. that we can tell them apart. There are five types of white blood cells. They are neu- Function trophils, eosinophils, basophils, monocytes and lymphocytes (Table 9-2). The function of all white blood cells is to provide a defense White blood cells can be classified in three different ways: for the body against foreign invaders. Each type of white 1. Type of defense function blood cell has its own unique role in this defense. If all the • Phagocytosis: neutrophils, eosinophils, basophils, mono- white blood cells are functioning properly, an animal has a cytes good chance of remaining healthy. Individual white blood • Antibody production and cellular immunity: lympho- cell functions will be discussed with each cell type (see cytes Table 9-2). 2. Shape of nucleus In providing defense against foreign invaders, the white • Polymorphonuclear (multilobed, segmented nucleus): blood cells do their jobs primarily out in the tissues. -
Hepcidin Is Not a Marker of Chronic Inflammation in Atherosclerosis Hepcidin Aterosklerozda Kronik Inflamasyonun Bir Göstergesi De¤Ildir
Original Investigation Orijinal Araflt›rma 239 Hepcidin is not a marker of chronic inflammation in atherosclerosis Hepcidin aterosklerozda kronik inflamasyonun bir göstergesi de¤ildir Aytekin O¤uz, Mehmet Uzunlulu, Nezih Hekim* Department of Internal Medicine, Göztepe Training and Research Hospital, ‹stanbul, Turkey *Pakize Tarz› Laboratory, ‹stanbul, Turkey ABSTRACT Objective: To investigate the relationship between atherosclerosis, an inflammatory disease and hepcidin which is reported as an indi- cator of inflammation Methods: A total of 75 subjects between 40 and 70 years of age were included in the study. The patient group consisted of 40 stable pa- tients who had previously experienced an atherosclerotic event (18 women, 22 men; mean age 56.4±7.1 years). There were two control groups. The first control group consisted of 19 healthy subjects (11 women, 8 men; mean age 52.6± 7.4 years), while the second group inc- luded 16 patients (11 women, 5 men; mean age 56.5±9.3 years) with rheumatoid arthritis and anemia (diseased control group). Hepcidin measurement was performed using Hepcidin Prohormone ELISA (Solid Phase Enzyme-Linked Immunosorbent Assay) test kit. Results: Mean serum hepcidin levels were 243.2±48.8 ng/ml, 374.5±86.4 ng/ml, and 234±59.9 ng/ml in the patient group, in diseased cont- rols, and in healthy controls, respectively. Hepcidin levels were higher in diseased controls compared to the patient group and healthy controls (p=0.001). There were no significant differences between the patient group and healthy controls. Conclusion: These findings did not support the hypothesis that hepcidin levels could be increased in atherosclerotic cardiovascular di- seases as a marker of chronic inflammation. -
Non-Commercial Use Only
Veins and Lymphatics 2012; volume 1:e6 Ulcerated hemosiderinic three months previous to this therapy. Significant improvement in these injuries, Correspondence: Eugenio Brizzio and Alberto dyschromia and iron deposits with a reduction in the dimensions of the Lazarowski, San Martín 965, 1st floor (Zip code within lower limbs treated brown spot (9 of 9) at Day 90, and complete 1004) Buenos Aires, Argentina. with a topical application scarring with a closure time ranging from 15 Tel. +54.11.4311.5559. to 180 days (7 of 9) were observed. The use of E-mail: [email protected]; of biological chelator [email protected]; topical lactoferrin is a non-invasive therapeu- [email protected]; tic tool that favors clearance of hemosiderinic 1 2 [email protected] Eugenio Brizzio, Marcelo Castro, dyschromia and scarring of the ulcer. The 3 2 Marina Narbaitz, Natalia Borda, success of this study was not influenced Key words: ulcerated haemosiderinic dyschro- Claudio Carbia,2 Laura Correa,4 either by the hemochromatosis genetics or mia, liposomal Lactoferrin, scarring, hemo- Roberto Mengarelli,5 Amalia Merelli,2 the iron metabolism profile observed. siderin-ferritin. Valeria Brizzio,2 Maria Sosa,6 Acknowledgments: the authors would like to Biagio Biancardi,7 Alberto Lazarowski2 thank P. Girimonte for her assistance with the statistical analysis of the results. We also wish to Introduction thank the patients who made this study possible. 1International Group of Compression and Conference presentation: part of the present Argentina Medical Association, Buenos Chronic venous insufficiency (CVI) is one of study has been presented at the following con- 2 Aires, Argentina; Department of Clinical the most significant health problems in devel- gresses: i) XX Argentine Congress of Hematology, Biochemistry, Institute of oped countries. -
Melanin-Dot–Mediated Delivery of Metallacycle for NIR-II/Photoacoustic Dual-Modal Imaging-Guided Chemo-Photothermal Synergistic Therapy
Melanin-dot–mediated delivery of metallacycle for NIR-II/photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy Yue Suna,1, Feng Dingb,1, Zhao Chenb,c,1, Ruiping Zhangd,1, Chonglu Lib, Yuling Xub, Yi Zhangb, Ruidong Nie, Xiaopeng Lie, Guangfu Yangb, Yao Sunb,2, and Peter J. Stangc,2 aKey Laboratory of Catalysis and Material Sciences of the State Ethnic Affairs Commission & Ministry of Education, College of Chemistry and Material Sciences, South-Central University for Nationalities, Wuhan 430074, China; bKey Laboratory of Pesticides and Chemical Biology, Ministry of Education, International Joint Research Center for Intelligent Biosensor Technology and Health, Chemical Biology Center, College of Chemistry, Central China Normal University, Wuhan 430079, China; cDepartment of Chemistry, University of Utah, Salt Lake City, UT 84112; dThe Affiliated Shanxi Da Yi Hospital, Shanxi Academy of Medical Sciences, Taiyuan 020001, China; and eDepartment of Chemistry, University of South Florida, Tampa, FL 33620 Contributed by Peter J. Stang, July 9, 2019 (sent for review May 22, 2019; reviewed by Phil S. Baran and Jean-Marie P. Lehn) Discrete Pt(II) metallacycles have potential applications in bio- compared with traditional methods such as vesicle carriers, mel- medicine. Herein, we engineered a dual-modal imaging and chemo- anin dots can load more drugs through π–π stacking on the high- photothermal therapeutic nano-agent 1 that incorporates discrete volume surface (16, 18). Recent studies reported that melanin Pt(II) metallacycle 2 and fluorescent dye 3 (emission wavelength in dots can absorb near-infrared (NIR) optical energy and convert it the second near-infrared channel [NIR-II]) into multifunctional into heat for photothermal therapy (PTT). -
Simple Technique to Identify Haemosiderin in Immunoperoxidase Stained Sections
J Clin Pathol: first published as 10.1136/jcp.37.10.1190 on 1 October 1984. Downloaded from 1190 Technical methods Phosphate buffer at pH 8*0 gave the sharpest 2 Rozenszajn L, Leibovich M, Shoham D, Epstein J. The esterase staining reactions, although there was little differ- activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol 1968; 14:605-19. ence at pH 7-0 or pH 7-5. As the buffer pH was 3Hayhoe FGJ, Quaglino D. Haematological cytochemistry. Edin- increased above pH 8-0 staining with both substrates burgh: Churchill Livingstone, 1980. became progressively weaker, especially above pH 4Li CY, Lam KW, Yam LT. Esterases in human leucocytes. J 9.0. Below pH 7-0 staining with a-naphthyl butyrate Histochem Cytochem 1973;21:1-12. Yam LT, Li CY, Crosby WH. Cytochemical identification of became weaker, and below pH 5*0 staining with monocytes and granulocytes. Am J Clin Pathol 1971;55:283- naphthol AS-D chloroacetate began to disappear. 90. 6 Armitage RJ, Linch DC, Worman CP, Cawley JC. The morphol- This work was supported by a Medical Research ogy and cytochemistry of human T-cell subpopulations defined by monoclonal antibodies and Fc receptors. Br J Haematol Council project grant. I thank Professor FGJ 1983;51:605-13. Hayhoe for valuable advice. References Requests for reprints to: Dr DM Swirsky, Department of Gomori G. Chloroacyl esters as histochemical substrates. J His- Haematological Medicine, University Clinical School, Hills tochem Cytochem 1953;1:469-70. Road, Cambridge CB2 2QL, England. Simple technique to identify identification of the two compounds on the same haemosiderin in slide. -
Hepcidin Therapeutics
pharmaceuticals Review Hepcidin Therapeutics Angeliki Katsarou and Kostas Pantopoulos * Lady Davis Institute for Medical Research, Jewish General Hospital, Department of Medicine, McGill University, Montreal, QC H3T 1E2, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-(514)-340-8260 (ext. 25293) Received: 3 November 2018; Accepted: 19 November 2018; Published: 21 November 2018 Abstract: Hepcidin is a key hormonal regulator of systemic iron homeostasis and its expression is induced by iron or inflammatory stimuli. Genetic defects in iron signaling to hepcidin lead to “hepcidinopathies” ranging from hereditary hemochromatosis to iron-refractory iron deficiency anemia, which are disorders caused by hepcidin deficiency or excess, respectively. Moreover, dysregulation of hepcidin is a pathogenic cofactor in iron-loading anemias with ineffective erythropoiesis and in anemia of inflammation. Experiments with preclinical animal models provided evidence that restoration of appropriate hepcidin levels can be used for the treatment of these conditions. This fueled the rapidly growing field of hepcidin therapeutics. Several hepcidin agonists and antagonists, as well as inducers and inhibitors of hepcidin expression have been identified to date. Some of them were further developed and are currently being evaluated in clinical trials. This review summarizes the state of the art. Keywords: iron metabolism; hepcidin; ferroportin; hemochromatosis; anemia 1. Systemic Iron Homeostasis Iron is an essential constituent of cells and organisms and participates in vital biochemical activities, such as DNA synthesis, oxygen transfer, and energy metabolism. The biological functions of iron are based on its capacity to interact with proteins and on its propensity to switch between the ferrous (Fe2+) and ferric (Fe3+) oxidation states. -
Hepcidin the Key Regulator of Iron in the Blood St
Hepcidin The Key Regulator of Iron in the Blood St. Dominic Middle School SMART Team Eclaire Jessup, Dominic Kowalik, Allyssa Larcheid, Samuel Larcheid, Claire Lois, Sara Maslowski, I. Introduction to Hepcidin and Iron Homeostasis Emma Pittman, Joseph Platz, Marissa Puccetti, Tyler Shecterle, Nicole Simson, Emma Wenger Abstract Hepcidin, a peptide hormone, is the key regulator of plasma iron levels in humans, and is known to play an important role in Iron is found everywhere on Earth and is essential to life. The human body contains 3-4 grams of iron Teacher: Ms. LaFlamme Mentor: Dr. Matthew S. Karafin, various human diseases, such as hemochromatosis. Hepcidin inhibits the entry of iron into circulation by binding to and over fifty percent is found in red blood cells (RBCs). Without iron, the oxygen carrying protein ferroportin, a trans-membrane iron export channel found primarily on enterocytes, hepatocytes and macrophages where iron Medical College of Wisconsin, The Blood Center of Wisconsin hemoglobin that fills RBCs cannot be made and the bone marrow cannot carry out erythropoiesis is sequestered. When hepcidin binds to ferroportin, both are drawn into the cell by endocytosis and degraded in a lysosome. When hepcidin levels increase, ferroportin levels on cells decrease and iron cannot be released from cells into the blood. (RBC production). All iron in the body is absorbed from the diet in the duodenum. Hepcidin production by the liver is affected by erythropoiesis in bone marrow, blood oxygenation, certain inflammatory The peptide hormone, hepcidin, controls the release of the dietary iron from duodenal enterocytes III. Hepcidin Structure & Function cytokines, intracellular iron storage, and plasma transferrin. -
The Correlation of the Hepcidin Ferritin Ratio and the Severity of Liver Cirrhosis
The Correlation of the Hepcidin Ferritin Ratio and the Severity of Liver Cirrhosis Imelda Rey1,2 *, Rustam Effendi-Ys1,3 and Khairani Sukatendel 4 1 Division of Gastroenterohepatology, Internal Medicine Department, Universitas Sumatera Utara , Medan, Indonesia 2 Adam Malik General Hospital, Medan, Indonesia 3 Pirngadi General Hospital, Medan, Indonesia 4 Department of Obstetric and Gynecology, Universitas Sumatera Utara, Medan, Indonesia Keywords: Hepcidin, Liver Cirrhosis, Severity. Abstract: Background. Hepcidin serum level was influenced by the inflammation and iron deposit in chronic liver disease / CLD), but the correlation between the hepcidin ferritin ratio and the severity of liver cirrhosis was still not clear. The aim of this study was to found correlation between the hepcidin ferritin ratio and the severity of liver cirrhosis. Methods. The study was conducted in Gastroenterohepatology Division, Internal Medicine Department, Faculty of Medicine, University of Sumatera Utara. The study was an analytic comparative, cross sectional study. The subject were liver cirrhosis patients that fulllfiled inclusion criteria and informed consent. Results. From 78 liver cirrhosis patients, mean age was 51.36 ± 12.6 years old. Male was more than female ( 44 (56%), 34 (43.6%), respectively. We found that there was no significant difference of the hepcidin ferritin ratio among Child pugh A , Child pugh B and Child pugh C patients (0.17 ; 0.11 and 0.28, respectively, with p = 0.161). Conclusion. There was no significant difference of the hepcidin ferritin ratio among severity of liver cirrhosis. 1 INTRODUCTION chronic liver disease (CLD), but less is known about the correlation between the ratio of hepcidin : Hepcidin is the hormone of iron which produced in ferritin and the severity of liver cirrhosis. -
Reprogramming of a Subpopulation of Human Blood Neutrophils By
Laboratory Investigation (2009) 89, 1084–1099 & 2009 USCAP, Inc All rights reserved 0023-6837/09 $32.00 Reprogramming of a subpopulation of human blood neutrophils by prolonged exposure to cytokines Arpita Chakravarti1, Daniel Rusu1, Nicolas Flamand2, Pierre Borgeat1 and Patrice E Poubelle1 Essential cells of innate immunity, neutrophils are often considered to be a homogenous population of terminally differentiated cells. During inflammation, neutrophils are extravasated cells exposed to local factors that prolong their survival and activate their production of mediators implicated in disease progression. In this study, a phenotypically distinct subset of human neutrophils that appear after prolonged exposure to cytokines was characterized. Freshly isolated neutrophils from healthy donors were incubated with granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-a and interleukin (IL)-4, three cytokines that are locally present in various inflammatory conditions. Eight to 17% of neutrophils survived beyond 72 h. This subset of non-apoptotic neutrophils, as evaluated by three different markers, was enriched by discontinuous Percoll gradient centrifugation before studying their phenotype. These viable neutrophils showed neoexpression of HLA-DR, CD80 and CD49d. Compared with freshly isolated neutrophils, they responded differentially to second signals similar to formyl-methionyl-leucyl-phenylalanine with three- to four-fold increases in production of superoxide anions and leukotrienes. These cells augmented their phagocytic index by 141%, increased their adhesion to human primary fibroblasts, but reduced their migration in response to chemotactic stimuli and decreased exocytosis of primary and secondary granules. In addition, they produced substantial amounts of IL-8, IL-1Ra and IL-1b. This neutrophil subset had a unique profile of phosphorylation of intracellular signaling molecules. -
On the Histological Diagnosis and Prognosis of Malignant Melanoma
J Clin Pathol: first published as 10.1136/jcp.33.2.101 on 1 February 1980. Downloaded from J Clin Pathol 1980, 33: 101-124 On the histological diagnosis and prognosis of malignant melanoma ARNOLD LEVENE Hunterian Professor, Royal College of Surgeons, and Department of Histopathology, The Royal Marsden Hospital, Fulham Road, London SW3, UK SUMMARY This review deals with difficulties of diagnosis in cutaneous malignant melanoma encountered by histopathologists of variable seniority and is based on referred material at The Royal Marsden Hospital over a 20-year period and on the experience of more than two-and-a-half thousand cases referred to The World Health Organisation Melanoma Unit which I reviewed when chairman of the Pathologists' Committee. Though there is reference to the differential diagnosis of primary and metastatic tumour, the main concern is with establishing the diagnosis of primary melanoma to the exclusion of all other lesions. An appendix on recommended diagnostic methods in cutaneous melanomas is included. Among the difficult diagnostic fields in histopathol- not to be labelled malignant because it 'looks nasty'. ogy melanocytic tumours have achieved a notoriety. Thus, until the critical evaluation of the 'malignant Accurate diagnosis, however, is of major clinical melanoma of childhood' by Spitz (1948) the naevus importance for the following reasons: with which this investigator's name is associated was 1 The management of the primary lesion is reckoned among the malignancies on histological principally by surgical excision with a large margin grounds. of normal appearing skin. The consequences of over-diagnosis are those of major disfiguring surgery Naevus and melanoma cells http://jcp.bmj.com/ and its morbidity. -
Ncomms4301.Pdf
ARTICLE Received 8 Jul 2013 | Accepted 23 Jan 2014 | Published 13 Feb 2014 DOI: 10.1038/ncomms4301 Genome-wide RNAi ionomics screen reveals new genes and regulation of human trace element metabolism Mikalai Malinouski1,2, Nesrin M. Hasan3, Yan Zhang1,4, Javier Seravalli2, Jie Lin4,5, Andrei Avanesov1, Svetlana Lutsenko3 & Vadim N. Gladyshev1 Trace elements are essential for human metabolism and dysregulation of their homoeostasis is associated with numerous disorders. Here we characterize mechanisms that regulate trace elements in human cells by designing and performing a genome-wide high-throughput siRNA/ionomics screen, and examining top hits in cellular and biochemical assays. The screen reveals high stability of the ionomes, especially the zinc ionome, and yields known regulators and novel candidates. We further uncover fundamental differences in the regulation of different trace elements. Specifically, selenium levels are controlled through the selenocysteine machinery and expression of abundant selenoproteins; copper balance is affected by lipid metabolism and requires machinery involved in protein trafficking and post-translational modifications; and the iron levels are influenced by iron import and expression of the iron/haeme-containing enzymes. Our approach can be applied to a variety of disease models and/or nutritional conditions, and the generated data set opens new directions for studies of human trace element metabolism. 1 Genetics Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. 2 Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, USA. 3 Department of Physiology, Johns Hopkins University, Baltimore, Maryland 21205, USA. 4 Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.